comparemela.com

Latest Breaking News On - Peter denardo - Page 2 : comparemela.com

Issue of Shares and Rule 2.9 Announcement | Company Announcement

Investegate announcements from Issue of Shares and Rule 2.9 Announcement

United-kingdom
London
City-of
Gary-clarence-shalin-bhamra
James-mccullough
Peter-denardo
International-securities-identification-number-for-the-ordinary
London-stock-exchange
Nasdaq
International-securities-identification-number
Panel-market-surveillance-unit
Investec-bank

Rule 2.9 Announcement | Company Announcement

Investegate announcements from Rule 2.9 Announcement

United-states
London
City-of
United-kingdom
American
Peter-denardo
James-mccullough
Gary-clarence-shalin-bhamra
Panel-market-surveillance-unit
Company-the-ordinary
Nasdaq
International-securities-identification-number-for-the-ordinary

Issue of Shares | Company Announcement

Investegate announcements from Issue of Shares

United-kingdom
London
City-of
James-mccullough
Peter-denardo
Gary-clarence-shalin-bhamra
Nasdaq
Investec-bank
International-securities-identification-number-for-the-ordinary
Panel-market-surveillance-unit
Company-the-ordinary
London-stock-exchange

Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024

LONDON and SALT LAKE CITY, Feb. 15, 2024 Renalytix plc , an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease, today.

London
City-of
United-kingdom
Gary-clarence-shalin-bhamra
James-mccullough
Paul-mcmanus-alice-woodings
Peter-denardo
Community-health
Exchange-commission
Drug-administration
National-government-services
Centers-for-medicare-medicaid-services

Renalytix Reports Financial Results for Second Quarter of

LONDON and SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) Renalytix plc (NASDAQ: RNLX) (LSE: RENX) (the “Company”), an artificial intelligence-enabled.

London
City-of
United-kingdom
James-mccullough
Peter-denardo
Paul-mcmanus-alice-woodings
Gary-clarence-shalin-bhamra
Nasdaq
National-government-services
Exchange-commission
Company-quarterly-report-on-form
Centers-for-medicare-medicaid-services

vimarsana © 2020. All Rights Reserved.